Interesting write-up. My first question was whether excess VEGF was a cause of asthma or an effect of it. The scientists in your article seem convinced it’s a cause.
There are even more companies pursuing therapies for asthma than there are pursuing therapies for AMD. MEDI better get cracking with their IL-9 blocker if they hope to make that drug a significant player in the respiratory arena.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”